Fayoum University

Assessment of Osteogenic Potential of Topical Metformin Gel on Bone Regeneration in Cystic Jaw Defects: Randomized Controlled Clinical Trial

No phase, Not yet recruiting, 2026, 32 people, clinicaltrials.gov

NCT07595705

Collaborator, Phase 2, Recruiting, 2025, 30 people, 19 May 2026, clinicaltrials.gov

NCT07536620

Phase 2, Not yet recruiting, 2026, 36 people, 17 Apr 2026, clinicaltrials.gov

NCT07147972

Phase 3, Not yet recruiting, 2025, 100 people, 29 Aug 2025, clinicaltrials.gov

NCT07070024

Phase 1/2, Not yet recruiting, 2025, 30 people, 17 Jul 2025, clinicaltrials.gov

NCT06975839

Phase 2, Not yet recruiting, 2025, 36 people, 16 May 2025, clinicaltrials.gov

NCT06709313

Phase 4, Active, not recruiting, 2024, 60 people, 29 Nov 2024, clinicaltrials.gov

NCT06496997

Phase 2/3, Completed, 2024, 195 people, 11 Jul 2024, clinicaltrials.gov

NCT05873673

Phase 2, Active, not recruiting, 2023, 20 people, 24 May 2023, clinicaltrials.gov

NCT05118685

Phase 1, Status unknown, 2021, 100 people, 12 Nov 2021, clinicaltrials.gov

NCT04617652

Phase 4, Completed, 2020, 60 people, 5 Nov 2020, clinicaltrials.gov

NCT04554862

Phase 4, Completed, 2019, 80 people, 18 Sept 2020, clinicaltrials.gov

NCT04532775

Phase 1, Status unknown, 2020, 100 people, 31 Aug 2020, clinicaltrials.gov

NCT04424875

Phase 3, Completed, 2020, 38 people, 11 Jun 2020, clinicaltrials.gov

NCT03064633

Phase 4, Completed, 2017, 54 people, 27 Feb 2017, clinicaltrials.gov

NCT02958306

Collaborator, Phase 2, Terminated, 2016, 24 people, 8 Nov 2016, clinicaltrials.gov